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Background: A novel multiple congenital anomalies syndrome has been recently identified in four patients
carrying a 8q12 microduplication sharing the smallest region of overlap (SRO, size 1.6 Mb) including five genes CA8,
ASPH, RAB2B, CLVS1 and CDH7. The phenotype is mainly characterized by neurodevelopmental delay, heart defects,
facial features and Type 1 Duane anomaly. Increasing dosage of CDH7 was proposed to be responsible for the
recurrent pattern of MCA.
Results: High resolution array-CGH analysis identified a 4.2 Mb de novo interstitial duplication of the 8q12.1-q12.3
chromosome region in a boy with developmental delay, dysmorphic features, type 3 Duane anomaly. This
duplication includes several genes and spans the SRO.
Discussion: The present case represents a further patient with an interstitial duplication of chromosome 8q12 and
several shared clinical features. Although more cases are needed to delineate the full-blown phenotype of 8q12
duplication syndrome, published data and present observations suggest that it results in a clinically recognizable
phenotype. The presence of Duane anomaly in four out of five described patients with a 8q12 duplication definitely
rules against the possibility of its being a chance finding unrelated to the imbalance and points toward a
pathogenic role. Gene content analysis of the duplicated region and review of the literature suggest that
gain-of-dosage of the CHD7 gene may be a good candidate for the main clinical features of the syndrome.
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Microduplication of 8q12, encompassing the CHD7 gene,
which is mutated or deleted in CHARGE syndrome, has
recently been identified to result in a novel multiple con-
genital anomalies syndrome. Hitherto four patients have
been described, with duplication sizes ranging from 2.7 to
6.9 Mb and different breakpoints within the 8q12 region
[1-4]. The phenotype, though variable, is mainly character-
ized by neurodevelopmental delay, heart defects, and facial
features. Type 1 Duane anomaly has been reported in
three out of the four described cases, the exception being
the child with the smaller duplication. Duane retraction
syndrome (DRS) is a highly heterogeneous eye-movement
disorder that in a quarter to half of cases is associated with* Correspondence: clara.bonaglia@bp.lnf.it
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[5]. Beyond the present microduplication, involvement of
chromosome 8 with Duane anomaly has been docu-
mented in mosaic trisomy 8 [6,7], in 8q13 deletions [8,9],
and in a de novo reciprocal balanced translocation dis-
rupting the CPA6 gene in 8q13 where the Duane retrac-
tion syndrome 1 locus (DURS1) is located [10].
Here we report on a further child who carries a de
novo 4.2 Mb duplication of the region 8q12.1-q12.3 pre-
senting with developmental delay, dysmorphic features,
and type 3 Duane anomaly in order to refine the clinical
presentation of the 8q12 microduplication syndrome
and to contribute to genotype-phenotype correlation.
Case presentation
The child was referred to our Clinical Genetics Service
for dysmorphic features and developmental delay. The
patient was the third child of healthy unrelated parentsal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of gestation, after a normal pregnancy, with urgent caesar-
ean section due to placental abruption. No intrauterine
exposure to drugs and other possibly harmful factors were
reported. At birth, weight was 2570 gr, length 47 cm, head
circumference 32 cm, and thoracic circumference 33 cm.
APGAR scores were 9/10 at 1’/5’, respectively. At cardio-
logical evaluation, a 2/6 systolic ejection murmur was de-
tected and an echocardiogram showed a patent foramen
ovale with left-to-right shunt, which spontaneously dis-
appeared within six months of life. Developmental delay
and muscle hypotonia were observed since the first
months of life.
On first examination at the Genetic Clinic, at age
16 months, he was 82 cm tall (75th centile), weighed
11.3 Kg (50th centile) and his head circumference was
45.2 cm (< 3rd centile). He had brachycephaly (cephalic
index: 87%), full cheeks, medial flaring of eyebrows, long
eyelashes, epicanthic folds, strabismus, normal ears with
total length of 4.7 cm (50th centile), short nose, low and
widened nasal root, long philtrum, full lower lip, tooth
enamel erosions. Chest circumference was 52 cm (75th
percentile) and the internipple distance was 13 cm (97th
percentile). Hands had normal length (50th-75th percent-
ile), tapering fingers and low set thumbs. Feet length
was 13 cm (75th percentile) (Figure 1B).
At age 28 months, stature and weight were respect-
ively at 97th and 75th percentile while head circumfer-
ence was still < 3rd percentile.
Motor skills were significantly delayed: he was able to
sit unassisted and to stand up without support since ageFigure 1 Molecular details and facial appearance of the patient. (A) A
duplication at 8q12.1q12.3; (right), enlargement of the 8q12.1q12.3 duplica
60,667 Mb to 64,709 Mb) are listed in grey, light blue, and orange. (B) Phot24 and 38 months, respectively, and began walking with
assistance since age 45 months. Language delay was
significant: at age 3 years and 9 months he vocalized but
didn’t yet use any word to communicate. At the same
age he had not yet achieved toilet training and head,
trunk and hand stereotypies, noted since the first year of
life, were still present though less common. Constipation
and feeding problems, mainly consisting in long feeding
times, difficulty chewing and fluids dysphagia, have been
moderately ameliorating over the years.
A MRI of the brain, at age 7 months, showed no abnor-
malities except for a thin corpus callosum. Abdominal
ultrasound was normal. Ear, nose and throat examination
didn’t disclose anomalies and brainstem auditory evoked
potentials were within normal limits. Ophthalmological
evaluation, at age 3 years, detected anisocoria (R > L), slight
inconstant nystagmus and exotropia in primary position of
the left eye; fundoscopy was normal. Examination of the
ocular motor system revealed in the left eye restricted
abduction and absent adduction with globe retraction
and palpebral fissure narrowing at attempted adduction
and concluded for a unilateral type 3 Duane syndrome.
Conventional cytogenetic studies showed a normal
karyotype (46,XY).
Results
In the absence of any etiological diagnosis, array CGH
analysis using the 180 K array platform was performed
in the patient detecting a 8q12.1q12.3 duplication of
4.2 Mb, as described in Figure 1A. Quantitative PCR
performed on the patient and his parents evidenced thatrray-CGH results. (left), array CGH profile of chromosome 8 showing a
ted region. Some of the genes included in the duplicated region (from
ograph of the patient at the age of 16 months.
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genotyping of polymorphic loci demonstrated the pater-
nal origin of the duplication (data not shown).
FISH analysis on metaphases from both proband’s
parents excluded the presence of insertional translocations
of 8q12.1q12.3 (data not shown). The final interpretation
of the rearrangement was arr[hg19] 8q12.1q12.3(60,637,
619×2,60,667,866-64,709,770×3,64,734,723×2)dn.
Discussion
With this case, five patients with partially overlapping
8q12 microduplications have been described, sharing
common features the most consistent of which, observed
in at least four subjects, are neonatal hypotonia, devel-
opmental delay, facial features, heart defects, and Duane
anomaly. A similar facial gestalt is noticed, with full
cheeks or round face, flared medial eyebrows, short nose
with widened root, long philtrum, full lower lip. Hearing
loss, urinary malformations, and microbrachycephaly ap-
pear inconstant findings, while variable behavioural anom-
alies, feeding problems and constipation are present in the
majority of cases. The smallest region of overlap (SRO)
between the published cases, including the present one, is
around 1.6 Mb and spans five genes: CA8, ASPH, RAB2B,
CLVS1, and CDH7. Up to now, only two of these genes,
CHD7 and CA8, have been linked to a human disease.
CHD7 haploinsufficiency, either by mutation or deletion,
is causative of the CHARGE syndrome. Homozygous mu-
tation in the CA8 gene, encoding carbonic anhydrase VIII,
has recently been found in Congenital ataxia with predis-
position to quadrupedal gait (OMIM #613227) [11].
The reported association of 8q12 microduplication and
DRS suggests a possible causal involvement of the dosage-
sensitive CHD7 gene [1-3].
In fact, in all patients the CHD7 gene is included in
the duplicated region but none of them has the distinct-
ive face nor fulfils the clinical criteria for typical or partial/
incomplete Charge syndrome according to Verloes’
categorization [12] and only in the child described by
Monfort et al. [1] a major sign of the syndrome, repre-
sented by a Mondini anomaly, was observed. Therefore,
CHD7 copy number increase doesn’t appear a likely
pathogenic mechanism underlying Charge’s aetiology.
Duane retraction syndrome (DRS) is a congenital ocular
motility disorder resulting in absent or marked restriction
of abduction (type 1), adduction (type 2), or both (type 3),
in addition to globe retraction and palpebral fissure nar-
rowing on attempted adduction, as a result of a congenital
anomaly of the 6th cranial nerve nuclei with paradoxical
innervation of the lateral rectus from the 3rd cranial
nerve. According to pooled data, type 1 is by far the most
common (78%), followed by type 3 (15%) and 2 (7%). Ap-
proximately 0,1% of the general population, without eth-
nic preferences, and 1-4% of all strabismus cases showDRS, with a predilection for unilateral involvement of the
left eye and for female patients [13].
Most cases are sporadic but familial transmission,
commonly autosomal dominant, has been documented
in several instances, usually in relation to isolated Duane
anomaly. Beside a number of recognizable syndromes
that are monogenic in origin, Duane anomaly has also
been observed in a variety of numerical and structural
chromosome aberrations involving different chromo-
somes, locations, and sizes. However, up to now the ma-
jority of these reports have been sporadic findings that
might represent chance association, whereas contribu-
tion of chromosomes 8 and 20 appears to be substantial.
DRS associated with interstitial deletion of the 20q13
region is probably due to haploinsufficiency of the
SALL4 gene, causative of the Duane-Radial Ray syn-
drome (OMIM #607323).
In addition to the present microduplication, involve-
ment of chromosome 8 with Duane anomaly has been
documented in mosaic trisomy 8 [6,7], and in 8q13 dele-
tions [8,9] although the precise localisation of the dele-
tions was not defined, since the paper was published
prior to the advent of microarrays.
Furthermore, a de novo balanced translocation dis-
rupting the CPA6 gene, located within the DURS1 locus
in 8q13, was reported in a patient exhibiting features of
Duane retraction syndrome [10]. As demonstrated in
zebra fish, conserved expression of CPA6 in cartilagin-
ous precursors posterior to the eye strongly suggests a
role in the aetiology of Duane anomaly. However, its
deficiency alone doesn’t affect development or function
of the VI nerve in the animal model and may not be
enough to cause the ocular motility disorder, requiring
interaction with other genes and/or enhancer elements
[14]. These data suggest that involvement of the 8q13
locus in Duane anomaly still remains uncertain, while
the presence of a Duane anomaly in four out of the five
described patients with a 8q12 triplication definitely
rules against the possibility of a coincidence unrelated
with the overlapping imbalances, as previously consid-
ered among the various hypotheses, and points toward a
pathogenic role.
Conclusion
In conclusion, our patient with 8q12 deletion of 4.2 Mb,
including the 1.6 Mb SRO, supports the hypothesis that
CHD7 might be the most likely candidate for generating
the main clinical features of the syndrome and influen-
cing the appearance of Duane anomaly.
Methods
Array-CGH analysis
Array-CGH was performed using the Agilent Human Gen-
ome CGH Microarray Kit 180 k (Agilent Technologies
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(Figure 1A). All nucleotide positions refer to the Human
Genome, Feb 2009 Assembly (hg19). Data analysis was
performed using Agilent Cytogenomics version 2.5.8.1.
Fish analysis
FISH was performed on both parents’ metaphases by using
Chr8:61591397-61780768 (hg19) SureFISH probes (Agilent
Technologies, Santa Clara, CA, USA) according to the
manufacturer’s protocol. This probe maps on chromosome
8 at the CHD7 gene.
Quantitative PCR
Quantitative PCR (qPCR) analysis was performed as in
[15]. The UCSC Genome Browser (Feb 2009 assembly;
http://genome.ucsc.edu/) maps and sequence were used
as references. Probe location was: RT1, chr8:61653966-
61654028; RT2, chr8:63979108-63979170. The sequences
of all primers used are available from the authors.
Genotyping
Genotyping of polymorphic loci in the proband and his
parents was performed by amplification of loci D8S260,
D8S1718, and D8S1178 with primers labelled with fluor-
escent probes (ABI 6-Fam, Tet, and Hex), followed by
analysis on ABI 3100 Genetic Analyzer (Applied Biosys-
tems, Foster City, CA). Locus location was verified on
the UCSC database.
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